Facing Uncertainty: Patients' Experiences with Stem Cell Therapy for Degenerative Diseases
Main Article Content
Abstract
Stem cell therapy represents a significant advancement in regenerative medicine, offering hope for patients with degenerative diseases. While clinical studies have explored its physiological outcomes, limited research has examined patients' lived experiences with this treatment. The gap in understanding patient perspectives, including their expectations, decision-making processes, and post-treatment reflections, necessitates qualitative inquiry. This study employs a phenomenological approach to investigate the subjective experiences of patients undergoing stem cell therapy. In-depth interviews and thematic analysis revealed four key themes: hope and motivation, uncertainty and anxiety, procedural experiences, and quality-of-life impact. Findings highlight the importance of clear doctor-patient communication and managing treatment expectations. This study contributes to patient-centered care strategies and calls for further exploration of cultural and ethical dimensions influencing stem cell therapy perceptions.
Article Details
References
Al-Massri, K. F., Ahmed, L. A., & El-Abhar, H. S. (2020). Mesenchymal stem cells in chemotherapy-induced peripheral neuropathy: A new challenging approach that requires further investigations. Journal of Tissue Engineering and Regenerative Medicine, 14(1), 108–122. Scopus. https://doi.org/10.1002/term.2972
Bhartiya, M., Kumar, A., Singh, R. K., Radhakrishnan, D. M., Rajan, R., & Srivastava, A. K. (2023). Mesenchymal Stem Cell Therapy in the Treatment of Neurodegenerative Cerebellar Ataxias: A Systematic Review and Meta-analysis. Cerebellum, 22(3), 363–369. Scopus. https://doi.org/10.1007/s12311-022-01403-6
He, L., Wang, S., Peng, L., Zhao, H., Li, S., Han, X., Habimana, J. D., Chen, Z., Wang, C., Peng, Y., Peng, H., Xie, Y., Lei, L., Deng, Q., Wan, L., Wan, N., Yuan, H., Gong, Y., Zou, G., … Jiang, H. (2021). CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells. Translational Psychiatry, 11(1). Scopus. https://doi.org/10.1038/s41398-021-01605-2
Huang, L., Zhao, Z., Wen, J., Ling, W., Miao, Y., & Wu, J. (2020). Cellular senescence: A pathogenic mechanism of pelvic organ prolapse (Review). Molecular Medicine Reports, 22(3), 2155–2162. Scopus. https://doi.org/10.3892/mmr.2020.11339
Kim, I.-K., Park, J.-H., Kim, B., Hwang, K.-C., & Song, B.-W. (2021). Recent advances in stem cell therapy for neurodegenerative disease: Three dimensional tracing and its emerging use. World Journal of Stem Cells, 13(9), 1215–1230. Scopus. https://doi.org/10.4252/wjsc.v13.i9.1215
Narzisi, A., Halladay, A., Masi, G., Novarino, G., & Lord, C. (2023). Tempering expectations: Considerations on the current state of stem cells therapy for autism treatment. Frontiers in Psychiatry, 14. Scopus. https://doi.org/10.3389/fpsyt.2023.1287879
Olufsen, M. E., Spindler, L., Sørensen, N. B., Christiansen, A. T., Alberti, M., Heegaard, S., & Kiilgaard, J. F. (2022). Controlled Subretinal Injection Pressure Prevents Damage in Pigs. Ophthalmologica, 245(3), 285–293. Scopus. https://doi.org/10.1159/000522110
O’neill, H. C., Limnios, I. J., & Barnett, N. L. (2019). Advancing a stem cell therapy for age-related macular degeneration. Current Stem Cell Research and Therapy, 15(2), 89–97. Scopus. https://doi.org/10.2174/1574888X15666191218094020
Perez, A. M., Chau, V. Q., & Sridhar, J. (2024). Medical Accuracy of Reddit in Patient Discussions of Prospective Ocular Stem Cell Therapies for Retinal Degenerative Diseases. Journal of VitreoRetinal Diseases, 8(4), 410–414. Scopus. https://doi.org/10.1177/24741264241246317
Poliwoda, S., Noor, N., Downs, E., Schaaf, A., Cantwell, A., Ganti, L., Kaye, A. D., Mosel, L. I., Carroll, C. B., Viswanath, O., & Urits, I. (2022). Stem cells: A comprehensive review of origins and emerging clinical roles in medical practice. Orthopedic Reviews, 14(3). Scopus. https://doi.org/10.52965/001C.37498
Scopetti, M., Santurro, A., Gatto, V., Russa, R. L., Manetti, F., Errico, S. D., Frati, P., & Fineschi, V. (2020). Mesenchymal stem cells in neurodegenerative diseases: Opinion review on ethical dilemmas. World Journal of Stem Cells, 12(3), 168–177. Scopus. https://doi.org/10.4252/wjsc.v12.i3.168
Shahin, S., Tan, P., Chetsawang, J., Lu, B., Svendsen, S., Ramirez, S., Conniff, T., Alfaro, J. S., Fernandez, M., Fulton, A., Laperle, A. H., Svendsen, C. N., & Wang, S. (2023). Human Neural Progenitors Expressing GDNF Enhance Retinal Protection in a Rodent Model of Retinal Degeneration. Stem Cells Translational Medicine, 12(11), 727–744. Scopus. https://doi.org/10.1093/stcltm/szad054
Yoo, M., Cho, S., Shin, S., Kim, J.-M., Park, H.-G., Cho, S., Hwang, Y. K., & Park, D. H. (2021). Therapeutic Effect of IL1β Priming Tonsil Derived-Mesenchymal Stem Cells in Osteoporosis. Tissue Engineering and Regenerative Medicine, 18(5), 851–862. Scopus. https://doi.org/10.1007/s13770-021-00350-3